-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U5L9Sg/EKmLK0y1Vxs+v8N+JLsIXxo0H+1Q0w25qyD0Pt9yPhkxW8QKiIx9f6b1x tp9+QupZ98amnGr9BMgUhg== 0001324517-07-000055.txt : 20070525 0001324517-07-000055.hdr.sgml : 20070525 20070525135242 ACCESSION NUMBER: 0001324517-07-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070523 FILED AS OF DATE: 20070525 DATE AS OF CHANGE: 20070525 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 07879953 BUSINESS ADDRESS: BUSINESS PHONE: 2037731450 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-05-23 1 0000890465 NPS PHARMACEUTICALS INC NPSP 0001206369 KLEIN JOSEPH III 383 COLOROW DRIVE SALT LAKE CITY UT 84108 0 0 0 1 as of May 22, 2007 Common Stock 2007-05-23 4 S 0 3100 4.10 D 35000 D Common Stock 2007-05-23 4 S 0 10000 4.0525 D 25000 D Common Stock 2007-05-23 4 S 0 10000 4.0521 D 15000 D Common Stock 2007-05-23 4 S 0 15000 4.0609 D 0 D Deferred Stock Units 0 Common Stock 49293 49293 D Mr. Klein ceased to be a Director on May 22, 2007 with the reduction in size of the Board of Directors and Mr. Klein not standing for re-election at the Annual Meeting of Stockholders. Mr. Klein has had no transactions in NPS stock within the previous six months or within the six months prior to cessation of director status. This transaction was not arranged prior to cessation of director status. Deferred Stock Units awarded under the Company's Nonemployee Director Compensation Program will be released six months after the date of separation from service as a director. Joseph Klein, III 2007-05-25 -----END PRIVACY-ENHANCED MESSAGE-----